Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TERAA: Tezepelumab in Emergency Room Asthma in Adults
NCT06705764Phase 4Recruiting
- Sponsor
- University of Alberta
- Start
- May 2026
- Primary completion
- Nov 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of tezepelumab in severe asthma, sponsored by University of Alberta. Started May 2026; status: recruiting.
02
Drugs
03
Conditions
severe asthma
Beyond the preview
Go deeper on NCT06705764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06705764.